Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice

[Image: see text] Recently, a commercial albumin-bound paclitaxel (PTX) nanocarrier (Abraxane) was approved as the first new drug for pancreatic ductal adenocarcinoma in almost a decade. PTX improves the pharmaceutical efficacy of the first-line pancreatic cancer drug, gemcitabine (GEM), through sup...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Huan, Wang, Meiying, Liu, Huiyu, Liu, Xiangsheng, Situ, Allen, Wu, Bobby, Ji, Zhaoxia, Chang, Chong Hyun, Nel, Andre E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415452/
https://www.ncbi.nlm.nih.gov/pubmed/25776964
http://dx.doi.org/10.1021/acsnano.5b00510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415452/
https://www.ncbi.nlm.nih.gov/pubmed/25776964
http://dx.doi.org/10.1021/acsnano.5b00510

Ejemplares similares